Sage Therapeutics, Inc. Stock
Stocks
SAGE
US78667J1088
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.680 USD | -0.23% |
|
-.--% | - |
| 25-07-31 | Supernus Pharmaceuticals Completes Sage Therapeutics Acquisition | MT |
| 25-07-31 | Sage Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 544M 478M 444M 408M 766M 52.64B 780M 5.31B 2.07B 25.68B 2.04B 2B 89.08B | P/E 2023 |
-2.39x | P/E 2024 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 50.98M 44.84M 41.65M 38.31M 71.84M 4.94B 73.13M 498M 194M 2.41B 191M 187M 8.35B | EV / Sales 2023 |
6.4x | EV / Sales 2024 | -3.89x |
| Free-Float |
99.75% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -0.23% |
| 1 year | 8.68 |  | 8.82 |
| 3 years | 4.62 | | 44.73 |
| 5 years | 4.62 | | 59.99 |
| 10 years | 4.62 | | 195.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
PSD | President | 64 | 2025-07-30 |
Tammy J. Phinney
LAW | General Counsel | - | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Khattar
BRD | Director/Board Member | 64 | 2025-07-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/25 | Issuer sale | Chief Technology Officer | 72,961 | 0.1187% | ||
| 7/31/25 | Issuer sale | Chief Financial Officer | 116,928 | 0.1902% | ||
| 7/31/25 | Tender | Director | 24,500 | 0.0398% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -.--% | -0.80% | -80.59% | 544M | |
| +1.23% | -3.08% | +53.96% | +87.98% | 55.27B | |
| +5.09% | +6.24% | +63.15% | +66.42% | 54.15B | |
| +0.45% | -0.10% | +3.78% | +424.68% | 23.11B | |
| -0.22% | +0.08% | -20.04% | -14.39% | 23.22B | |
| +1.03% | -0.76% | +40.14% | -3.59% | 20.33B | |
| -0.37% | +0.71% | +31.36% | -29.32% | 17.91B | |
| +0.87% | -2.80% | +37.96% | +600.00% | 15.76B | |
| -2.54% | -12.88% | +168.62% | +289.45% | 15B | |
| +0.75% | -0.65% | +21.85% | +178.13% | 13.82B | |
| Average | +0.61% | -0.33% | +40.00% | +151.88% | 23.91B | |
| Weighted average by Cap. | +1.46% | +1.19% | +45.29% | +140.35% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 86.46M 76.04M 70.64M 64.97M 122M 8.37B 124M 845M 329M 4.08B 325M 318M 14.17B | 41.24M 36.27M 33.7M 30.99M 58.12M 3.99B 59.16M 403M 157M 1.95B 155M 151M 6.76B |
| Net income | -541M -476M -442M -407M -763M -52.44B -777M -5.29B -2.06B -25.58B -2.03B -1.99B -88.74B | -401M -352M -327M -301M -565M -38.8B -575M -3.91B -1.53B -18.93B -1.5B -1.47B -65.66B |
| Net Debt | -748M -658M -611M -562M -1.05B -72.44B -1.07B -7.31B -2.85B -35.33B -2.81B -2.75B -123B | -493M -433M -402M -370M -694M -47.7B -707M -4.81B -1.88B -23.27B -1.85B -1.81B -80.72B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SAGE Stock
Select your edition
All financial news and data tailored to specific country editions
